Potential Therapeutic Effects of a GLP-1 Analogue on Blood Pressure in Morbidly Obese Patient: A Case Report
This case report demonstrates that treatment with a GLP-1 analogue in a morbidly obese patient with a BMI of 62.84 kg/m² resulted in significant weight loss and a reduction in blood pressure sufficient to discontinue antihypertensive medications, with the patient maintaining a mean blood pressure of 113/74 mmHg at a BMI of 47.37 kg/m².
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.